157 related articles for article (PubMed ID: 101159)
21. Antidiabetic activity and toxicity of Zizyphus spina-christi leaves.
Abdel-Zaher AO; Salim SY; Assaf MH; Abdel-Hady RH
J Ethnopharmacol; 2005 Oct; 101(1-3):129-38. PubMed ID: 16009520
[TBL] [Abstract][Full Text] [Related]
22. Glucose modulates the amount, but not the kinetics, of insulin released by sulfonylureas.
Gregorio F; Ambrosi F; Filipponi P; Cristallini S; Santeusanio F
J Diabetes Complications; 1994; 8(4):204-12. PubMed ID: 7833495
[TBL] [Abstract][Full Text] [Related]
23. Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice.
Kim CH; Park SH; Sim YB; Kim SS; Kim SJ; Lim SM; Jung JS; Suh HW
Brain Res; 2014 May; 1564():33-40. PubMed ID: 24713348
[TBL] [Abstract][Full Text] [Related]
24. Changes in plasma amino acids levels and "in vivo" gluconeogenesis from alanine in rats chronically treated with sulfonylureas.
Alemany M; Palou A; Codina J; Herrera E
Diabete Metab; 1978 Sep; 4(3):181-6. PubMed ID: 101403
[No Abstract] [Full Text] [Related]
25. [Insulin and pro-insulin secretion following intravenous administration of tolbutamide, glisoxepide and glibenclamide].
Hausmann L; Schumann G; Kaffarnik H
Arzneimittelforschung; 1978; 28(1):83-6. PubMed ID: 415745
[TBL] [Abstract][Full Text] [Related]
26. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
Szoke E; Gosmanov NR; Sinkin JC; Nihalani A; Fender AB; Cryer PE; Meyer C; Gerich JE
Metabolism; 2006 Jan; 55(1):78-83. PubMed ID: 16324923
[TBL] [Abstract][Full Text] [Related]
27. Gliflumide, a new oral antidiabetic of high potency and efficacy.
Blumenbach L; Gerhards E; Gutsche H; Klein W; Loge O; Losert W; Schillinger E; Speck U; Vetter H; Wendt H
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):141-51. PubMed ID: 809367
[TBL] [Abstract][Full Text] [Related]
28. [Experimental study of glipizide. A comparison with other hypoglycemic sulfonamides (author's transl)].
Loubatières AL; Loubatieres-Mariani MM; Alric R; Ribes G; Sorial G; Tarasco A
Diabete Metab; 1975 Mar; 1():13-21. PubMed ID: 824163
[TBL] [Abstract][Full Text] [Related]
29. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
Haupt E; Beyer J; Schöffling K
Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
[No Abstract] [Full Text] [Related]
30. Insulin exocytosis in Goto-Kakizaki rat beta-cells subjected to long-term glinide or sulfonylurea treatment.
Kawai J; Ohara-Imaizumi M; Nakamichi Y; Okamura T; Akimoto Y; Matsushima S; Aoyagi K; Kawakami H; Watanabe T; Watada H; Kawamori R; Nagamatsu S
Biochem J; 2008 May; 412(1):93-101. PubMed ID: 18254725
[TBL] [Abstract][Full Text] [Related]
31. The effect of oral sulphonylureas on blood glucose and insulin.
Adadevoh BK; Bolodeoku JO
Ghana Med J; 1973 Dec; 12(4):360-5. PubMed ID: 4282692
[No Abstract] [Full Text] [Related]
32. Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
Beck-Nielsen H; Hjøllund E; Pedersen O; Richelsen B; Sørensen NS
Diabetes Care; 1984; 7 Suppl 1():100-5. PubMed ID: 6428842
[TBL] [Abstract][Full Text] [Related]
33. [Comparative studies between HB 419 (glibenclamide) and tolbutamide on their effect on insulin liberation in isolated islands of rat pancreas in vitro].
Weinges KF; Biro G; Kettl H; Mitzuno M
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1467-9. PubMed ID: 4899089
[No Abstract] [Full Text] [Related]
34. Cardiovascular effects of conventional sulfonylureas and glimepiride.
Geisen K; Végh A; Krause E; Papp JG
Horm Metab Res; 1996 Sep; 28(9):496-507. PubMed ID: 8911987
[TBL] [Abstract][Full Text] [Related]
35. [Comparative use of gliquidone and tolbutamide administered intravenously].
Zilker T; Lüders L; Bottermann P
MMW Munch Med Wochenschr; 1975 Sep; 117(36):1421-2. PubMed ID: 126376
[No Abstract] [Full Text] [Related]
36. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
Haupt E; Beyer J; Schöffling K
Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
[No Abstract] [Full Text] [Related]
37. [Effect of glycemia level on insulin secretion caused by an hypoglycemic sulfamide (glisoxepide) in dogs].
Loubatières AL; Ribes G; Loubatières-Mariani MM
C R Seances Soc Biol Fil; 1972; 166(8):1047-50. PubMed ID: 4573746
[No Abstract] [Full Text] [Related]
38. A comparison of the effects of tolazamide and tolbutamide upon blood glucose and serum insulin and lipid levels in diabetic subjects.
Moorhouse JA
Can Med Assoc J; 1967 Mar; 96(9):536-9. PubMed ID: 6019354
[TBL] [Abstract][Full Text] [Related]
39. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo(b)furan-m-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). I. Pharmacological studies on the hypoglycaemic effect.
Jorgensen KD
Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):216-26. PubMed ID: 402791
[TBL] [Abstract][Full Text] [Related]
40. Hypoglycemic and hypotriglyceridemic effects of tolbutamide in triphenyltin chloride-induced diabetic rabbits.
Watanabe M; Watanabe K; Matsui H
Vet Hum Toxicol; 2002 Jun; 44(3):140-4. PubMed ID: 12046964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
